Cette liste est basée sur les listes de surveillance des personnes sur Stock Events qui suivent BBP. Il ne s'agit pas d'une recommandation d'investissement.
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing.